Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)
44.96
0.00 (0.00%)
USD |
NASDAQ |
Aug 01, 16:00
Cerevel Therapeutics Holdings Total Liabilities (Quarterly): 562.89M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 562.89M |
| December 31, 2023 | 569.55M |
| September 30, 2023 | 549.00M |
| June 30, 2023 | 543.85M |
| March 31, 2023 | 498.64M |
| December 31, 2022 | 496.58M |
| September 30, 2022 | 490.35M |
| June 30, 2022 | 143.84M |
| Date | Value |
|---|---|
| March 31, 2022 | 97.05M |
| December 31, 2021 | 110.19M |
| September 30, 2021 | 104.40M |
| June 30, 2021 | 97.12M |
| March 31, 2021 | 68.07M |
| December 31, 2020 | 60.75M |
| September 30, 2020 | 7.930M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.930M
Minimum
Sep 2020
569.55M
Maximum
Dec 2023
293.35M
Average
143.84M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| AbbVie Inc | 137.35B |
| Amgen Inc | 83.36B |
| Biogen Inc | 11.95B |
| Gilead Sciences Inc | 36.14B |
| Eli Lilly and Co | 61.29B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.127B |
| Shareholders Equity (Quarterly) | 564.46M |